Open Access Research article

Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece

Nikos Maniadakis1, Georgia Kourlaba1*, Theodoros Mougiakos2, Ioannis Chatzimanolis3 and Linus Jonsson4

Author Affiliations

1 Department of Health Services Organization & Management, National School of Public Health, 196 Alexandras Avenue, Athens 11521, Greece

2 Psychiatric clinic, 414 Military Hospital, Athens, Greece

3 Psychiatry Department, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece

4 Optuminsight, Stockholm, Sweden

For all author emails, please log on.

BMC Health Services Research 2013, 13:173  doi:10.1186/1472-6963-13-173

Published: 10 May 2013

Additional files

Additional file 1:

Relapse survival curve.

Format: DOC Size: 28KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 2:

Resource utilization (excluding management of adverse events and antidepressants) and unit costs.

Format: DOC Size: 36KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 3:

Distributions and model parameters used in the stochastic analysis.

Format: DOC Size: 251KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data